1Pellis T, Weil M H, Tang W, et al. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation [J]. Circulation, 2003, 108(21): 2716-2721.
2Cammarata G, Well M H, Sun S, et al. Beta 1-Adrenergic blockade during cardiopulmonary resuscitation improves survival [J]. Crit Care Med, 2004, 32(9 Suppl): S440-443.
4L u J, Zhang Y, Wei J, et al. Effect and mechanism of esmolol given during carcliopulmonary resuscitation in a porcine ventricular fibrillation model [J]. Resuscitation, 2009, 80 (9): 1052-1059.
5Huang L, Weil M H, Sun S, et al. Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation [J]. Cardiovasc Pharmacol Ther, 2005, 10(2): 113-120.
6Sun S, Weil M H, Tang W, et al. alpha-Methylnorepinephrine, a selective alpha2-adrenergic agonist for cardiac resuscitation[J]. J Am Coll Cardiol 2001, 37(3): 951-956.
7Klouche K, Weil M H, Tang W, et al. A selective alpha (2) -adrenergic agonist for cardiac resuscitation[J]. J Lab Clin Med 2002, 140(1): 27-34.
8Klouche K, Weil M H, Sun S, et al. A comparison of alphamethylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation[J]. Resuscitation, 2003, 57(1): 93-100.
9Wenzel V, Linder K H, Krismer A C, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs[J]. J Am Coll Cardiol, 2000, 35(2):527-533.
10Prengel A W, Linstedt U, Zenz M, et al. Effects of combined administration of vasopressin, epinephrine, and norepinephrine during cardiopulmonary resuscitation in pigs[J]. Crit Care Med, 2005, 33(11): 2587-91.
